Found: 7
Select item for more details and to access through your institution.
Response-Guided ABVD Chemotherapy plus Involved-Field Radiation Therapy for Intermediate-Stage Hodgkin Lymphoma in the Pre–Positron Emission Tomography Era: A Gruppo Italiano Studio Linfomi (GISL) Prospective Trial.
- Published in:
- Clinical Lymphoma & Myeloma, 2009, v. 9, n. 2, p. 138
- By:
- Publication type:
- Article
Use of intrapleural bortezomib in myelomatous pleural effusion.
- Published in:
- 2007
- By:
- Publication type:
- Letter
Monoclonal antibodies: potential new therapeutic treatment against multiple myeloma.
- Published in:
- European Journal of Haematology, 2013, v. 90, n. 6, p. 441, doi. 10.1111/ejh.12107
- By:
- Publication type:
- Article
Assessment of the frequency of additional cancers in patients with splenic marginal zone lymphoma.
- Published in:
- European Journal of Haematology, 2006, v. 76, n. 2, p. 134, doi. 10.1111/j.1600-0609.2005.00578.x
- By:
- Publication type:
- Article
Deoxycoformycin (pentostatin) in the treatment of splenic marginal zone lymphoma (SMZL) with or without villous lymphocytes.
- Published in:
- European Journal of Haematology, 2005, v. 75, n. 2, p. 130, doi. 10.1111/j.1600-0609.2005.00426.x
- By:
- Publication type:
- Article
Hepatitis B virus reactivation and alemtuzumab therapy.
- Published in:
- European Journal of Haematology, 2005, v. 74, n. 3, p. 254, doi. 10.1111/j.1600-0609.2004.00375.x
- By:
- Publication type:
- Article
Splenic marginal zone lymphoma with or without villous lymphocytes: Hematologic findings and outcomes in a series of 57 patients.
- Published in:
- Cancer (0008543X), 2004, v. 101, n. 9, p. 2050
- By:
- Publication type:
- Article